Hypoxia, Brain: Clinical Trials

36 trials for Hypoxia, Brain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 3 terminated, 3 unknown, 3 withdrawn. 36 Phase 1, 16 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 136Completed 21, Terminated 3, Unknown 3, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2, Enrolling by invitation 1, Recruiting 1
Phase 216Completed 10, Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1

Follow Hypoxia, Brain: new trials by email Literature Review of Hypoxia, Brain trials Research Report on Hypoxia, Brain

Trials (filtered) newest first · largest first

All 36 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy
Wharton's jelly-derived mesenchymal stem cells, 0.9 % Normal Saline - Hypoxic-Ischemic Encephalopathy, Neonatal, Brain Injuries, Hypoxic-Ischemic
Phase 1 / Phase 2Not yet recruitingMahidol University402026-09-152026-09-02
Hydrogen In Neonatal Encephalopathy (HIE) Trial
Hydrogen Gas (H2) - HIE, Hypoxic-Ischemic Encephalopathy
Phase 1Not yet recruitingBoston Children's Hospital542026-03-012026-02-17
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
Metformin - Hypoxic-Ischemic Encephalopathy, HIE
Phase 1Enrolling by invitationBoston Children's Hospital302025-10-012026-02-17
Dose Optimization of Caffeine for HIE
Caffeine citrate 20 mg/kg, Caffeine citrate 30 mg/kg - Hypoxic-Ischemic Encephalopathy
Phase 1Active not recruitingUniversity of North Carolina, Chapel Hill162024-07-262026-08-14
PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
Caffeine citrate - Acute Kidney Injury, Hypoxic-Ischemic Encephalopathy
Phase 1WithdrawnUniversity of Arkansas2024-05-082024-05-10
Metformin Treatment in Infants After Perinatal Brain Injury
Metformin Hydrochloride - Hypoxic Ischemic Encephalopathy of Newborn, Premature Birth
Phase 1TerminatedThe Hospital for Sick Children12023-05-022024-03-07
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain
Phase 1 / Phase 2RecruitingUniversity of Calgary122023-01-012026-05-01
Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease
Hypoxic Gas Mixture - Parkinson Disease, Effect of Drug
Phase 1 / Phase 2CompletedRadboud University Medical Center292022-02-222023-07-21
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
Methylphenidate - Brain Injury Traumatic Severe (Diagnosis), Coma
Phase 1Active not recruitingMassachusetts General Hospital102020-08-242025-10-29
The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy
CL2020 cells - Hypoxia-Ischemia, Brain
Phase 1CompletedNagoya University92020-03-042023-10-03
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
HB-adMSCs - Traumatic Brain Injury
Phase 1 / Phase 2CompletedHope Biosciences LLC242020-01-012026-11-09
Caffeine for Hypoxic-Ischemic Encephalopathy
Caffeine Citrate 5 mg/kg, Caffeine Citrate 10 mg/kg - Hypoxic-Ischemic Encephalopathy
Phase 1CompletedUniversity of North Carolina, Chapel Hill172019-08-142025-03-27
Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE
Infusion of hCT-MSC - Moderate to Severe Hypoxic-ischemic Encephalopathy
Phase 1CompletedJoanne Kurtzberg, MD62018-12-272024-04-12
Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia
autologous umbilical cord blood (UCB), standard care - Hypoxic-Ischemic Encephalopathy, Hypoxia Neonatal
Phase 1UnknownMononuclear Therapeutics Ltd.402018-04-162018-06-07
Sildenafil Administration to Treat Neonatal Encephalopathy
Sildenafil, Ora-Blend - Neonatal Encephalopathy
Phase 1CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre282016-07-012022-02-08
TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA
2-Iminobiotin - Cardiac Arrest, Hypoxic Ischemic Brain Injury
Phase 1 / Phase 2TerminatedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)212016-05-012021-02-18
Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2
5% carbon-dioxide inhalation - Hypoxic-Ischaemic Encephalopathy, Perinatal Asphyxia
Phase 1CompletedSemmelweis University102016-02-012021-04-26
Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
Autologous cord blood, Hypothermia - Hypoxic Ischemic Encephalopathy, Cerebral Infarction
Phase 1 / Phase 2WithdrawnChildren's Hospital of Fudan University2015-09-082023-12-29
Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
Autologous umbilical cord blood cells - Neonatal Encephalopathy, Hypoxic-ischemic Encephalopathy
Phase 1CompletedNeonatal Encephalopathy Consortium, Japan62014-08-012019-10-29
Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
Melatonin, placebo - Newborn Hypoxic Ischemic Encephalopathy
Phase 1WithdrawnSt. Louis University2014-04-012015-07-03

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Hypoxia-Ischemia, Brain (34)  ·  Asphyxia Neonatorum (5)  ·  Brain Injuries (3)  ·  Hypothermia (3)  ·  Asphyxia (2)  ·  Intracranial Hemorrhages (2)  ·  Stroke (2)  ·  Acute Kidney Injury (1)  ·  Anemia, Neonatal (1)  ·  Brain Injuries, Traumatic (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Cerebral Infarction (1)  ·  Cerebral Palsy (1)  ·  Coma (1)

Broader conditions

Brain Diseases (36)  ·  Central Nervous System Diseases (36)  ·  Nervous System Diseases (36)  ·  Pathological Conditions, Signs and Symptoms (36)  ·  Signs and Symptoms (36)  ·  Signs and Symptoms, Respiratory (36)  ·  Cardiovascular Diseases (35)  ·  Cerebrovascular Disorders (35)  ·  Hypoxia (35)  ·  Vascular Diseases (35)  ·  Brain Ischemia (34)  ·  Pathologic Processes (6)  ·  Wounds and Injuries (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)

Interventions

Saline Solution (3)  ·  caffeine citrate (3)  ·  Bumetanide (2)  ·  Epoetin Alfa (2)  ·  Erythropoietin (2)  ·  Metformin (2)  ·  2-iminobiotin (1)  ·  5,10-dihydro-5-methylphenazine (1)  ·  Cerebrovascular Circulation (1)  ·  Clonidine (1)  ·  Cool-Down Exercise (1)  ·  Core Binding Factors (1)  ·  Darbepoetin alfa (1)  ·  Endothelium-Dependent Relaxing Factors (1)  ·  Hypothermia, Induced (1)

Sponsors

Boston Children's Hospital (2)  ·  University of California, San Francisco (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Zhengzhou University (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Children's Hospital of Fudan University (1)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  Hebei Medical University (1)  ·  Hope Biosciences LLC (1)  ·  Joanne Kurtzberg, MD (1)  ·  Johns Hopkins University (1)  ·  Kristin R Hoffman (1)  ·  Mahidol University (1)  ·  Massachusetts General Hospital (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

Countries

United States (16)  ·  China (4)  ·  Canada (3)  ·  Netherlands (3)  ·  Japan (2)  ·  United Kingdom (2)  ·  Egypt (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  India (1)  ·  Ireland (1)  ·  Singapore (1)  ·  Sweden (1)  ·  Thailand (1)

Top investigators

Brian Kalish, MD (2)  ·  Changlian Zhu, MD, PhD (2)  ·  Wesley M Jackson, MD, MPH (2)  ·  Yvonne W Wu, MD, MPH (2)  ·  Balraj Guhan, MD (1)  ·  Baoyong Yan, Doctor (1)  ·  Brian L Edlow, MD (1)  ·  Brian T Kalish, MD (1)  ·  Charles M Cotten, MD MHS (1)  ·  Charles S Cox, MD (1)  ·  Cheo Lian Yeo, MBBS (1)  ·  Estelle B Gauda, MD (1)  ·  Farouk Sadiq, MD (1)  ·  Haruo Shintaku, MD, PhD (1)  ·  Janet Soul, MD,CM (1)

Results publications

PMID 24524452, PMID 15199405, PMID 19172693, PMID 19883750, PMID 20385632, PMID 20631189, PMID 23008465, PMID 23133515, PMID 24388332, PMID 25439577, PMID 25765333, PMID 25794112, PMID 27535166, PMID 27632779, PMID 28949952, PMID 29016557, PMID 29769612, PMID 30661082, PMID 31261373, PMID 32813884, PMID 33362471, PMID 34482377, PMID 35473726, PMID 35836147, PMID 37199820, PMID 37422495, PMID 37587184, PMID 38142044, PMID 38902120, PMID 39401019, PMID 39498807, PMID 40850908

NIH funding

DP2HD101400 (1), K23HD111623 (1), R01NS066929 (1)